The fate of U1 snRNP during anti-Fas induced apoptosis: Specific cleavage of the U1 snRNA molecule

Cell Death and Differentiation

Volumn 7, Issue 1, 2000, Pages 70-79

  Degen, W G J ^a   Van Aarssen, Y ^a   Pruijn, G J M ^a   Utz, P J ^b   Van Venrooij, W J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Apoptosis; Caspase; U1 snRNA; U1 snRNP; U1 70K

Indexed keywords

CASPASE INHIBITOR; FAS ANTIGEN; GUANOSINE; RIBONUCLEASE; SMALL NUCLEAR RIBONUCLEOPROTEIN; SMALL NUCLEAR RNA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA CLEAVAGE;

EID: 0034098897     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400617     Document Type: Article

References (50)

1. Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44: 93-152
2. van Venrooij WJ and Sillekens PT (1989) Small nuclear RNA associated proteins: autoantigens in connective tissue diseases. Clin. Exp. Rheumatol. 7: 635-645
3. Hoet RMA, Kastner B, Luhrmann R and van Venrooij WJ (1993) Purification and characterization of human autoantibodies directed to specific regions on U1RNA; recognition of native U1RNP complexes. Nucleic. Acids. Res. 21: 5130-5136
4. Hoet RMA, De Weerd P, Klein Gunnewiek JMT, Koornneef I and van Venrooij WJ (1992) Epitope regions on U1 small nuclear RNA recognized by anti-U1RNA-specific autoantibodies. J. Clin. Invest. 90: 1753-1762
5. Hoet RMA, Koornneef I, de Rooij DJ, van de Putte LB and van Venrooij WJ (1992) Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome. Arthritis Rheum. 35: 1202-1210
6. Klein Gunnewiek JMT, van de Putte LB and van Venrooij WJ (1997) The U1 snRNP complex: an autoantigen in connective tissue diseases. An update. Clin. Exp. Rheumatol. 15: 549-560
7. Vaishnaw AK, McNally JD and Elkon KB (1997) Apoptosis in the rheumatic diseases. Arthritis Rheum. 40: 1917-1927
8. Casiano CA, Ochs RL and Tan EM (1998) Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes. Cell Death Differ. 5: 183 - 190
9. Casciola Rosen LA, Anhalt G and Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179: 1317-1330
10. Casciola Rosen LA, Anhalt GJ and Rosen A (1995) DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J. Exp. Med. 182: 1625-1634
11. Casciola Rosen LA, Rosen A, Petri M and Schlissel M (1996) Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc. Natl. Acad. Sci. U.S.A. 93: 1624-1629
12. Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem. J. 326: 1-16
13. Utz PJ and Anderson P (1998) Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum. 41: 1152-1160
14. Sharp PA (1994) Split genes and RNA splicing. Cell 77: 805-815
15. Tazi J, Kornstadt U, Rossi F, Jeanteur P, Cathala G, Brunel C and Luhrmann R (1993) Thiophosphorylation of U1-70K protein inhibits pre-mRNA splicing. Nature 363: 283-286
16. Casciola Rosen LA, Miller DK, Anhalt GJ and Rosen A (1994) Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J. Biol. Chem. 269: 30757-30760
17. Casciola Rosen LA, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK and Rosen A (1996) Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Exp. Med. 183: 1957-1964
18. Utz PJ, Hottelet M, van Venrooij WJ and Anderson P (1998) Association of phosphorylated serine/arginine (SR) splicing factors with the U1-small ribonueleoprotein (snRNP) autoantigen complex accompanies apoptotic cell death. J. Exp. Med. 187: 547-560
19. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL and Henson PM (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148: 2207-2216
20. Vaux DL, Cory S and Adams JM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442
21. Hockenbery D, Nunez G, Milliman C, Schreiber RD and Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336
22. Habets WJ, Hoet RMA, De Jong BA, Van der Kemp A and van Venrooij WJ (1989) Mapping of B cell epitopes on small nuclear ribonucleoproteins that react with human autoantibodies as well as with experimentally-induced mouse monoclonal antibodies. J. Immunol. 143: 2560-2566
23. Hoet RMA, Raats JMH, de Wildt RM, Dumontier H, Muller S, van den Hoogen F and van Venrooij WJ (1999) Human monoclonal antibody fragments from combinatorial antibody libraries directed to the U1snRNP associated U1C protein; epitope mapping, immunolocalization and V-gene usage. Mol. Immunol. 35: 1045-1055
24. Williams DG, Stocks MR, Smith PR and Maini RN (1986) Murine lupus monoclonal antibodies define five epitopes on two different Sm polypeptides. Immunology 58: 495-500
25. Casiano CA, Martin SJ, Green DR and Tan EM (1996) Selective cleavage of nuclear autoantigens during CD95 (Fas/APO- 1)-mediated T cell apoptosis. J. Exp. Med. 184: 765-770
26. Strasser A, Harris AW, Huang DC, Krammer PH and Cory S (1995) Bcl-2 and Fas/ APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14: 6136-6147
27. Memon SA, Moreno MB, Petrak D and Zacharchuk CM (1995) Bcl-2 blocks glucocorticoid-but not Fas- or activation-induced apoptosis in a T cell hybridoma. J. Immunol. 155: 4644-4652
28. Cuppen E, Nagata S, Wieringa B and Hendriks W (1997) No evidence for involvement of mouse protein-tyrosine phosphatase-BAS-like Fas-associated phosphatase-1 in Fas-mediated apoptosis. J. Biol. Chem. 272: 30215-30220
29. Teunissen SW, Stassen MH, Pruijn GJM, van Venrooij WJ and Hoet RMA (1998) Characterization of an anti-RNA recombinant autoantibody fragment (scFv) isolated from a phage display library and detailed analysis of its binding site on U1 snRNA. RNA. 4: 1124-1133
30. Theissen H, Etzerodt M, Reuter R, Schneider C, Lottspeich F, Argos P, Luhrmann R and Philipson L (1986) Cloning of the human cDNA for the U1 RNA-associated 70K protein. EMBO J. 5: 3209-3217
31. Nelissen RL, Will CL, van Venrooij WJ and Luhrmann R (1994) The association of the U1-specific 70K and C proteins with U1 snRNPs is mediated in part by common U snRNP proteins. EMBO J. 13: 4113-4125
32. Reddy R and Busch H (1988) Small nuclear RNAs: RNA sequences, structure and modifications. In: Structure and function of major and minor small nuclear ribonucleoprotein particles. Birnstiel ML (ed). Springer-Verlag Press. pp. 1-37
33. Massenet S, Mougin A and Branlant C (1998) Posttranscriptional modifications in the U small nuclear RNAs. In: Modification and editing of RNA. Grosjean H and Benne R (eds). ASM Press. pp. 201-227
34. Crawford DR, Lauzon RJ, Wang Y, Mazurkiewicz JE, Schools GP and Davies KJ (1997) 16S mitochondrial ribosomal RNA degradation is associated with apoptosis. Free Radic. Biol. Med. 22: 1295-1300
35. Houge G, Doskeland SO, Boe R and Lanotte M (1993) Selective cleavage of 28S rRNA variable regions V3 and V13 in myeloid leukemia cell apoptosis. FEBS Lett. 315: 16-20
36. Houge G, Robaye B, Eikhom TS, Golstein J, Mellgren G, Gjerteen BT, Lanotte M and Doskeland SO (1995) Fine mapping of 28S rRNA sites specifically cleaved in cells undergoing apoptosis. Mol. Cell Biol. 15: 2051-2062
37. Rutjes SA, van der Heijden A, Utz PJ, van Venrooij WJ and Fruijn GJM (1999) Rapid nucleolytic degradation of the small cytoplasmic YRNAs during apoptosis. J. Biol. Chem. 274: 24799-24807
38. Guthrie C and Patterson B (1988) Spliceosomal snRNAs. Annu. Rev. Genet. 22: 387-419
39. Lamond Al (1993) The spliceosome. Bioessays 15: 595-603
40. Steitz JA, Black DL, Gerke V, Parker KA, Kramer A, Frendewey D and Keller W (1988) Functions of abundant U-snRNPs. In: Structure and function of major and minor small nuclear ribonucleoprotein particels. Birnstiel ML (ed). Springer-Verlag Press. pp. 115-154
41. Temsamani J, Agrawal S and Pederson T (1991) Biotinylated antisense methylphosphonate oligodeoxynucleotides. Inhibition of spliceosome assembly and affinity selection of U1 and U2 small nuclear RNPs. J. Biol. Chem. 266: 468-472
42. Rensing-Ehl A, Frei K, Flury R, Matiba B, Mariani SM, Weller M, Aebischer P, Krammer PH and Fontana A (1995) Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur. J. Immunol. 25: 2253-2258
43. Utz PJ, Hottelet M, Schur PH and Anderson P (1997) Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp. Med. 185: 843-854
44. de Rooij DJ, van de Putte LB, Habets WJ, Verbeek AL and van Venrooij WJ (1988) The use of immunoblotting to detect antibodies to nuclear and cytoplasmic antigens. Clinical and serological associations in rheumatic diseases. Scand. J. Rheumatol. 17: 353-364
45. Lerner EA, Lerner MR, Janeway Jr CA and Steitz JA (1981) Monoclonal antibodies to nucleic acid-containing cellular constituents: probes for molecular biology and autoimmune disease. Proc. Natl. Acad. Sci. U.S.A. 78: 2737-2741
46. Billings PB, Allen RW, Jensen FC and Hoch SO (1982) Anti-RNP monoclonal antibodies derived from a mouse strain with lupus-like autoimmunity. J. Immunol. 128: 1176-1180
47. Degen WGJ, Weterman MA, van Groningen JJ, Cornelissen IM, Lemmers JP. Agterbos MA, Geurts van Kessel A, Swart GW and Bloemers HP (1996) Expression of nma, a novel gene, inversely correlates with the metastatic potential of human melanoma cell lines and xenografts. Int. J. Cancer 65: 460-465
48. de Wildt RM, Finnern R, Ouwehand WH, Griffiths AD, van Venrooij WJ and Hoet RMA (1996) Characterization of human variable domain antibody fragments against the U1 RN A-associated A protein, selected from a synthetic and pat ent-derived combinatorial V gene library. Eur. J. Immunol. 26: 629-639
49. van Gelder CW, Thijssen JP, Klaassen EC, Sturchler C, Krol A, van Venrooij WJ and Pruijn GJM (1994) Common structural features of the Ro RNP associated hY1 and hY5 RNAs. Nucleic. Acids. Res. 22: 2498-2506
50. Boelens WC, Jansen EJ, van Venrooij WJ, Stripecke R. Mattaj IW and Gunderson SI (1993) The human U1 snRNP-specific U1A protein inhibits polyadenylation of its own pre-mRNA. Cell 72: 881-892